A Prospective, Randomized, Open, Multicenter Study to Evaluate the Efficacy and Tolerability of Induction Therapy With a Single High-Dose Anti-T-Lymphocyte Globulin (ATG) in Renal Transplant Patients With a Kidney From a Non-Heart-Beating Donor and Tacrolimus, Mycophenolate Mofetil, and Steroids as Basic Immunosuppression
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Antithymocyte globulin (Primary) ; Mycophenolate mofetil; Prednisolone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 06 Sep 2008 New trial record.